Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined intra-articular corticosteroid and exercise in knee osteoarthritis
2012-002607-18Phase 4
Key facts
- Status
- Completed
- Start
- Aug 2012
- Countries
- 1
- Sponsor
- Marius Henriksen
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Drugs
- methylprednisolone
- Conditions
- knee osteoarthritis (OA)
01
Overview
Phase 4, randomised trial of methylprednisolone in knee osteoarthritis (OA) (2 arms), sponsored by Marius Henriksen. Primary endpoint: Change in KOOS pain subscale. Started Aug 2012; status: completed.
02
Design
2 arms- Study design
- Randomized
Methylprednisolone acetate + exercise
Participants receive a single intra-articular injection of methylprednisolone acetate followed by a physiotherapeutic exercise program.
Saline + exercise
Participants receive a single intra-articular injection of saline (placebo) followed by the same physiotherapeutic exercise program.
03
Who it enrols
Adults aged 40 years and older with knee osteoarthritis; exclusion of patients who have participated in a physiotherapy exercise program within the last 3 months.
04
Endpoints
Primary
Change in KOOS pain subscale
Secondary
Change from baseline in secondary outcomes
Beyond the preview
Go deeper on 2012-002607-18.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002607-18.